Citation Impact
Citing Papers
1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee.
1993
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
1999
Effects of Psychological Stress and Psychiatric Disorders on Blood Coagulation and Fibrinolysis: A Biobehavioral Pathway to Coronary Artery Disease?
2001
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
2001 Standout
Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases
2008 StandoutNobel
Medical Treatment of Peripheral Arterial Disease and Claudication
2001
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
Does the vagus nerve mediate the sixth sense?
2001
Drug penetration in solid tumours
2006 Standout
New Antithrombotic Drugs
2012
Weak opioids - an educational substitute for morphine?
1998
Platelet-Active Drugs
1998
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Exercise Standards for Testing and Training
2013 Standout
C-reactive protein: a critical update
2003 Standout
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
1998
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Antiplatelet Drugs
2012
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation
2005
High-Dose Tramadol in Comparison to Low-Dose Morphine for Cancer Pain Relief
1999
Antiplatelet Drugs
2008
Is the Placebo Powerless?
2001
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Diabetes and Atherosclerosis
2002 Standout
Simultaneous analysis of vascular norepinephrine and ATP release using an integrated microfluidic system
2016
Prevention of Venous Thromboembolism
2004 Standout
Variability of tumor response to chemotherapy II. Contribution of tumor heterogeneity
1988
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
2001
Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer
1995
Clinical Pharmacology of Tramadol
2004 Standout
Sympathetic neural mechanisms in obstructive sleep apnea.
1995 Standout
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Soluble endoglin contributes to the pathogenesis of preeclampsia
2006 Standout
Placebo interventions for all clinical conditions
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Endothelial Dysfunction and Coronary Risk Reduction
1998
Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
2004 Standout
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
2002 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Mental Depression and Cardiovascular Disease: A Multifaceted, Bidirectional Association
2009
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension
2001
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Neural and psychologic mechanisms and the problem of sudden cardiac death
1977
Cardiovascular Regulation during Sleep
1980
Tracking of 24-hour and casual blood pressure
2000
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Psychosocial Influences on Mortality after Myocardial Infarction
1984 Standout
Effect of growth factors on human vascular endothelial cell prostacyclin production.
1990
Current and Future Drug Therapies for Claudication
1997
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
BINDING PROPERTIES AND SPECIFICITY OF C-REACTIVE PROTEIN
1967 StandoutNobel
How do you feel? Interoception: the sense of the physiological condition of the body
2002 Standout
Aspirin and Other Platelet-Active Drugs
1992
PLACEBO-CONTROLLED COMPARISON OF CAPTOPRIL, ATENOLOL, LABETALOL, AND PINDOLOL IN HYPERTENSION COMPLICATED BY INTERMITTENT CLAUDICATION
1987
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
2000
Cilostazol Has Beneficial Effects in Treatment of Intermittent Claudication
1998
Placebo interventions for all clinical conditions
2010
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
C-reactive protein: a molecule composed of subunits.
1965 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
1992
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC).
1995 StandoutNobel
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Coronary Plaque Disruption
1995 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Role of Tobacco Cessation, Antiplatelet and Lipid-Lowering Therapies in the Treatment of Peripheral Arterial Disease
1997
STUDIES OF ACUTE PHASE PROTEIN
1961
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
C-reactive protein: a critical update
2003 Standout
General Cardiovascular Risk Profile for Use in Primary Care
2008 Standout
Metabolism of oxazaphosphorines
1988
Emerging Droplet Microfluidics
2017 Standout
Utility of blood pressure monitoring outside of the clinic setting.
2002
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
Plasma protein insudation as an index of early coronary atherogenesis.
1993
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Works of A Libretti being referenced
Inhibitory control of sinocarotid pressoceptive afferents on hypothalamic autonomic activity and sham rage behavior
1960
Immunologic Relationships of C-Reactive Protein from Various Human Pathologic Conditions
1957
Isolated office hypertension: are there any markers of future blood pressure status?
2000
Decreased fibrinolytic response to adrenergic stimulation in hypertensive patients
1989
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.
1980
190 Ambulatory and home blood pressure reference values
1993
Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial.
1996
Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.
1989
Role of the Sympathetic Nervous System in Spontaneous Hypertension: Changes in Central Adrenoceptors and Plasma Catecholamine Levels
1981
Plasma and Tissue Distribution of Adriamycin in Patients with Pelvic Cancer
1981
Placebo effect and adaptation to noninvasive monitoring of BP.
1990
Tonic reflex regulation of the cat's blood pressure through vagal afferents from the cardiopulmonary region.
1962
Reduced serotonin uptake by spontaneously hypertensive rat platelets
1981
Defective Fibrinolytic Response in Atherosclerotic Patients – Effect of lloprost and Its Possible Mechanism of Action
1988
Treatment of claudication with dipyridamole and aspirin.
1986
Captopril for the Treatment of Patients with Hypertension and Peripheral Vascular Disease
1985
Blood Pressure Levels in Adolescents: The Milan Study
1986
Ambulatory blood pressure normalcy: the PAMELA Study.
1991
Adriamycin distribution in plasma and blood cells of cancer patients with altered hematocrit
1981